Roivant Sciences stock hits all-time high at 30.31 USD
Roivant Sciences (ROIV) stock has reached an all-time high of $30.31, leading to a market capitalization of $21.66 billion and a 185.38% increase over the past year. This surge is attributed to investor confidence in the company's biotech innovations, recent settlements, and promising clinical pipeline developments. Analysts have reacted positively, raising price targets and reiterating "Buy" and "Outperform" ratings, although InvestingPro data suggests the stock might be overvalued.
https://www.investing.com/news/company-news/roivant-sciences-stock-hits-alltime-high-at-3031-usd-93CH-4555012